glp-1 in pregnancy GLP1-RAs: The New Era of Diabetes and Weight Loss Management, FAQs and Lactation Use of GLP-1 drugs early

Taking differences in quantities of peptide administered via the intestine compared with i.v

This presents a significant cost burden for injectable weight loss drugs

2014;55(2):e213

Obesity, Weight Gain, and the Risk of Kidney Stones

Safety, Sourcing, and Why Medical Oversight Is Non-Negotiable BPC-157 has a strong safety record in animal studies notably, the lethal dose (LD1) has not been achieved across decades of preclinical research, and it has been used in human ulcerative colitis and multiple sclerosis trials without reported toxicity.6 But the absence of adverse events in animals does not translate directly to human safety, particularly at unregulated doses from unverified sources

In our clinical practice, a baseline brain MRI is offered to patients with large CMN overlying the lower spine which may prompt referral to neurology or ongoing monitoring, although some parents choose to forego imaging given the limited available interventions